Crystal Pollock‐Dove
Papers
2
Total Citations
76
H-Index
2
About
Crystal Pollock‐Dove is a pharmaceutical scientist whose research focuses on enhancing the oral bioavailability of poorly water-soluble drugs, a critical challenge in drug development. Her major contributions center on innovative formulation strategies that prevent drug precipitation in the gastrointestinal tract, ensuring more consistent and effective absorption. In her highly cited 2012 study (41 citations), she demonstrated a novel combination approach using solubilization agents and precipitation inhibitors to maintain drug solubility as it moves from the stomach to the small intestine, significantly improving bioavailability for weakly basic compounds. Earlier, in 2006 (35 citations), she pioneered a parallel screening method that allows researchers to identify optimal solubility-enhancing formulations using only milligram quantities of material—a breakthrough that accelerates early-stage drug development while conserving precious compounds. Her work has provided practical, scalable solutions for the pharmaceutical industry, bridging the gap between laboratory discovery and clinical application. Pollock‐Dove’s research remains foundational for scientists tackling the persistent problem of poor drug solubility, offering both mechanistic insights and actionable formulation tools.
Research Focus
Key Achievements
Top Papers
- 1
- 2